21 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
for healthcare professionals, and elements to assure a product’s safe use (“ETASU”). ETASU can include, but are not limited to, special training … received her MD and PhD from the Free University in Amsterdam, The Netherlands, and post-doctoral training at the Dana-Farber Cancer Institute, Harvard
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
include, but are not limited to, special training or certification for prescribing or dispensing the product, dispensing the product only under certain … training at the Dana-Farber Cancer Institute, Harvard Medical School. From 2005 to 2016, she led her own research group at The University of Texas Health
8-K
EX-10.5
22iuptt
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.3
wxjy oxnotczgvz9
20 Sep 23
Entry into a Material Definitive Agreement
4:52pm
DRS
weat8fh
14 Aug 23
Draft registration statement
12:00am
DEF 14A
xylag4c
1 May 23
Definitive proxy
2:55pm
PRE 14A
30n5gmnbewk2i0mm 9e2
19 Apr 23
Preliminary proxy
9:56pm
8-K
EX-99.1
xr3i6
15 Dec 22
Other Events
1:26pm
424B4
gyg63ufljw6csrvs8
2 Sep 22
Prospectus supplement with pricing info
3:25pm